SOLASTA BIO

SOLASTA® Bio Expands Patent Portfolio and Reports Strong Global Field Trial Results

SOLASTA® Bio now holds 14 granted patents for its peptide-based bioinsecticides, including eight in the U.S. and six in Europe.

Read More